Molecular dynamics simulation of four-α-helix bundles that bind the anesthetic halothane  by Davies, Lowri A. et al.
Molecular dynamics simulation of four-K-helix bundles that bind the
anesthetic halothane
Lowri A. Daviesa, Qingfeng Zhonga, Michael L. Kleina;*, Daphna Scharfb
aCenter for Molecular Modeling, Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA
bDepartment of Anesthesia, University of Pennsylvania Medical Center, Philadelphia, PA 19104-4283, USA
Received 23 February 2000; revised 16 June 2000
Edited by Maurice Montal
Abstract The mutation of a single leucine residue (L38) to
methionine (M) is known experimentally to significantly increase
the affinity of the synthetic four-K-helix bundle (AK2)2 for the
anesthetic halothane. We present a molecular dynamics study of
the mutant (AK2^L38M)2 peptide, which consists of a dimer of
62-residue U-shaped di-K-helical monomers assembled in an anti
topology. A comparison between the simulation results and those
obtained for the native (AK2)2 peptide indicates that the overall
secondary structure of the bundle is not affected by the mutation,
but that the side chains within the monomers are better packed in
the mutant structure. Unlike the native peptide, binding of a
single halothane molecule to the hydrophobic core of (AK2^
L38M)2 deforms the helical nature of one monomer in a region
close to the mutation site. Increased exposure of the cysteine
side chain to the hydrophobic core in the mutant structure leads
to the enhancement of the attractive interaction between
halothane and this specific residue. Since the mutated residues
are located outside the hydrophobic core the observed increased
affinity for halothane appears to be an indirect effect of the
mutation. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
An understanding of the structural features of binding sites
for inhaled anesthetics on proteins has been extensively pur-
sued by many di¡erent approaches. Inhaled anesthetics alter
the function of numerous membrane ion channels [1,2] and
ion transport proteins [3], however, the mechanism involved
remains poorly understood. Do these anesthetics bind to spe-
ci¢c sites in membrane proteins or is there an indirect e¡ect
due to the perturbation of the lipid membrane by the anes-
thetics? Current opinion favors the former explanation [4^6]
and several experimental studies have illustrated the existence
of discrete sites for anesthetics in membrane and in water
soluble proteins [4]. The complexity of membrane protein
and current experimental limitations hinder direct probing
of inhaled anesthetics binding sites in protein. Experimental
advances with de novo synthetic peptides [7^11], which model
native proteins, suggest an alternative approach. More specif-
ically, the introduction of a simple cavity [12^14] into a de-
signed four-K-helix structure by replacing six core leucines
with alanines increases the a⁄nity of the peptide for the anes-
thetic halothane (CF3CBrClH) by a factor of 4.4 [11]. In
addition, when L at position 38 is replaced with M (see Fig.
1), experimental studies show that this mutated peptide (AK2^
L38M)2 has a higher a⁄nity (by a factor of 3.4) for halothane
compared with the native (AK2)2 one [15]. Such design-depen-
dent phenomena indicate the importance of studying synthetic
peptides whose structural features can be carefully controlled
and monitored. Another advantage of model systems with
known amino acid sequences and secondary structure, is
that they can also be examined using computer simulation
techniques such as molecular dynamics (MD). By using this
approach detailed information can be obtained with respect to
the peptide^anesthetic interactions, in particular the existence
of attractive interactions between halothane and speci¢c ami-
no acid side chains are isolated.
Several plausible explanations have been advanced for the
increased halothane a⁄nity of (AK2^L38M)2 [15]: the opti-
mized size of the cavity inside the four-K-helix sca¡old due to
the smaller size of the M side chain; the direct interaction of
halothane with the M side chain due to a favorable electro-
static contribution; and the increased access to the hydropho-
bic core for the anesthetic molecules due to the higher mobil-
ity of the M side chain. However, conclusive experimental
evidence in support of any of these proposals is limited.
Therefore, the aim of this theoretical study is to provide in-
sight into the structure and changes that may occur in the
bundle (AK2^L38M)2 as a result of the single mutation and
halothane binding.
2. Simulation system and methodology
The four-K-helix peptide studied consists of two 62-residue
U-shaped di-K-helical monomers, denoted as AK2, each composed
of two 27-residue K-helical stretches joined by an 8-residue £exible
G linker. The sequence is based on prior designs [16^18] and is known
experimentally to be water soluble and to bind halothane with high
a⁄nity in the hydrophobic core, as probed by quenching of the £uo-
rescence emission of the two W residues. The two monomers can
associate in either an anti [17,19] or syn [20,21] topology. Both exper-
imental [11] and MD simulation [22] results indicate that the anti
topology of the native (AK2)2 peptide is more energetically favorable.
Thus we only perform simulations for the mutant peptide (AK2^
L38M)2 in the anti topology. Residues on di¡erent monomers are
distinguished by the label B.
The initial coordinates for the mutant peptide were obtained from a
fully equilibrated con¢guration of the native peptide (AK2)2 in aque-
ous solution taken from our work [22] after 1 ns of constant pressure
and temperature (NPT) molecular dynamics at P = 1 atm and T = 298
K, which we summarize herein. Insight II software (Molecular Simu-
lation Inc., San Diego, CA 92121, USA, Version 97.2) was utilized to
construct the AK2 di-K-helical monomer. Two AK2 monomers were
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positioned in anti topology at a distance, which allowed for residual
dimer interaction. The resulting structure was placed to a pre-equili-
brated water solvent environment (T = 298 K and P = 1 atm) and any
overlapping water molecules were removed. The simulation system
thus consisted of the peptide in a box with dimensions of
56U56U75 Aî 3 containing V6600 water molecules, with the long
axis of the protein placed parallel to the long axis of the box.
Initial minimization of the system was performed using the steepest
descent algorithm in CHARMM [23], which ensures that none of the
protein atoms has any unfavorable contacts with one another or with
any of the water molecules. Equilibration of the system consisted of
200 ps constant volume and temperature (NVT) MD at T = 298 K,
followed by 150 ps of constant NPT MD at P = 1 atm and T = 298 K.
An NPT MD trajectory was then generated for 1 ns at P = 1 atm and
T = 298 K. The multiple time-step MD simulation algorithm of the
PINY-MD computational package was implemented [24,25], which
incorporates features such as periodic boundary conditions, Nose¤^
Hoover chain thermostats and PME-Ewald to evaluate the long-range
interactions [26]. The interaction energy of the system consists of both
intra- and inter-molecular components; bond stretching, bond^angle
bending and torsions were all explicitly accounted for. The inter-mo-
lecular interactions were repulsive at short separations and attractive
at intermediate separations; electrostatic interactions are also included
in the total potential energy function. The AMBER-95 parameter set
[27^29] was used to describe the protein interactions and the TIP3P
model [30] for water was employed. All the O^H bonds in water and
the bonds formed with hydrogen in the protein were constrained to
their equilibrium value, enabling a time-step of 6 fs to be used.
To construct the mutant bundle (AK2^L38M)2, the two L residues
at position 38 and 38B were mutated to M in the equilibrated struc-
ture of (AK2), using Insight II software. The resulting structure was
placed back to the water solvent environment and any overlapping
water molecules were removed. The same equilibration procedure as
described for AK2 was used to equilibrate the mutant bundle (AK2^
L38M)2. Energy conservation combined with diminishing RMS devi-
ations for structural properties (e.g. inertia tensor, lengths of the heli-
ces, secondary structure i and P angles) were used to determine equi-
librium.
Following 1 ns of dynamics two cavities exist between the four-K-
helices in the mutant (AK2^L38M)2 structure, each is large enough to
accommodate a single halothane molecule. A single halothane mole-
cule was placed in one of the hydrophobic cavities and an additional
set of MD simulations were performed for the mutant bundle with a
halothane molecule. This choice of initial condition was directed by
the experimental results [11,15]. We note that in the anti topology the
two hydrophobic cavities are identical due to symmetry.
Halothane was initially constructed using Insight II and the inter-
action parameters of Scharf and Laasonen [31] were used; the cross
terms were evaluated with the Lorentz^Bertholot mixing rules. As for
the system without halothane, minimization procedure was per-
formed, followed by 200 ps of constant NVT MD at T = 298 K,
and 150 ps of constant NPT simulation at P = 1 atm and T = 298
K, before a 1 ns MD trajectory was generated. On the timescale of
the simulation the halothane molecule can rotate and translate in the
cavity.
3. Results and discussion
During 1 ns of simulation the peptide sca¡old of (AK2^
L38M)2 remains stable. Each of the four K-helices retains a
high degree of K-helicity, and they twist to form a right-
handed coiled-coil bundle. All the hydrophilic residues occupy
positions, which maximize their contact with water, while the
hydrophobic residues remain inside the core of the bundle. At
equilibrium no water molecules are found within this hydro-
phobic region. Other structural features such as the compo-
nents of the inertia tensor, and the lengths of the helices, only
show small £uctuations during the simulation. These proper-
ties of the mutant (AK2^L38M)2 mimic those observed for the
simulation of the native (AK2)2 peptide [22].
One signi¢cant di¡erence between the overall structures of
the mutant and native peptides is the increased interaction
between the two K-helices on the same monomer in the mu-
tant (AK2^L38M)2 protein. This results in an improved pack-
ing of hydrophilic side chains between the two K-helices con-
nected by the G linker. Consequently the hydrophobic
residues between the two monomers are more exposed to
the solvent than in the native (AK2)2 structure (see Fig. 2).
This altered arrangement of side chains with respect to the
solvent in the mutant (AK2^L38M)2 peptide can be under-
stood in terms of the variation of interactions between amino
acid side chains in the vicinity of the mutation site. For exam-
ple, the interaction between E27 and M38 (and between E27B
and M38B) during the simulation has a signi¢cantly attractive
van der Waals component whereas there is no corresponding
attraction between E27 and L38 in the native (AK2)2 peptide.
Substitution of a single L with M in each monomer thus
enhances the attractive interactions between side chains on
the same AK2^L38M monomer, which leads to their closer
proximity and hence improved packing.
The relative position of the mutated residue M38 with re-
spect to that of L38 in the native peptide is not signi¢cantly
di¡erent, both residues occupy a region that is not completely
within the hydrophobic core of the four-K-helix structure (see
Fig. 3). The inter-facial position of this residue in both the
native and mutant structures suggests that the main e¡ect of
the mutation is not the direct alteration of the size of the
cavity within the core of the peptide, but the in£uence of
neighboring residues, which leads to other structural changes
in the four-K-helix sca¡old (at least in the absence of halo-
thane). Since the mutation of L38 to M38 does not alter the
relative position of these residues it is possible that the struc-
tural e¡ects of the mutation might be very di¡erent for the
syn topology of (AK2^L38M)2, since both L38 and L38B oc-
cupy positions within the hydrophobic core of the native syn
(AK2)2 peptide [22]. Further simulations are required in order
to quantify this speculation.
When a single halothane molecule is placed in one of the
two equivalent cavities, which exists in the core of the four-K-
helix structure, features such as the components of the inertia
tensor and overall degree of K-helicity are not signi¢cantly
di¡erent compared to those observed for the system in the
absence of halothane. This is consistent with the e¡ect of
addition of halothane to the native peptide [22]. However,
upon closer examination of the mutant four-K-helix bundle
Fig. 1. Sequences of the di-K-helical monomers (a) native and (b)
mutant. The hydrophobic residues, which occupy the heptad a and
d positions inside the core of the bundle are shown in bold italics
and the mutated residue is underlined. In the experimental design of
the halothane cavity, six Leu residues were replaced by Ala in posi-
tions 9, 19, 23, 44, 45, and 48 [11] to produce the AK2.
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several interesting features are observed, which are the direct
result of the presence of the anesthetic within the hydrophobic
core of (AK2^L38M)2.
Halothane remains within the core of the mutant (AK2^
L38M)2 structure during the simulation and exhibits complex
translational and rotational dynamics within a single cavity.
Although mobile, it occupies a position, which is consistently
closer to one of the AK2^L38M monomers, as was observed
for the native peptide [22]. The orientation of halothane in the
mutant (AK2^L38M)2 bundle is such that it prefers to be in a
position where the C^C axis of the anesthetic molecule is
parallel to the long axis of the protein, with the tri-£uorinated
end towards the G loop region, and the bromine and chlorine
atoms are closest to W16. No preferred orientation of the
anesthetic is observed in the native (AK2)2 peptide [22].
The interaction energy between halothane and a peptide
residue side chain was calculated by taking the sum of the
corresponding electrostatic and van der Waals components.
The interaction energy between halothane and the M side
chain is not signi¢cantly di¡erent as compared to the very
slightly attractive interaction, which exists between the anes-
thetic and L38 in the native (AK2)2 structure. Additionally,
the location of M38 is not altered due to the presence of
halothane in the simulation, i.e. it does not occupy a position
within the hydrophobic core. On a single ns timescale, there is
no direct contact between halothane and the mutated residue
(see Fig. 3). The e¡ect of the mutation on the protein^anes-
thetic interactions is likely to occur indirectly, and not as a
result of the increased a⁄nity of halothane for M rather than
L.
Halothane dynamics in proximity to the mutation site in
(AK2^L38M)2 leads to the localized deformation of the sec-
ondary structure of one monomer in the peptide sca¡old, see
Fig. 4. The loss of the K-helical character of the protein in this
region is illustrated by the di¡erence in values of the torsional
angles about the protein backbone between the system with
and without halothane. The largest deviation from K-helicity
occurs in the region of C41. Such a dramatic alteration in
structure due to the presence of halothane was not observed
in the native (AK2)2 peptide [22]. This phenomenon appears to
be the result of a combination of e¡ects whereby the anes-
thetic molecule is altering speci¢c interactions within the pro-
tein sca¡old, thus causing a deformity in the K-helix close to
the mutation site. For example, the interaction between hal-
othane and C41 is signi¢cantly more attractive for the mutant
(AK2^L38M)2 peptide than in the native system. The loss of
K-helicity in the mutant peptide in the vicinity of C41 suggests
that it is this large attractive interaction between C41 and
halothane, which is responsible for this structural change.
However, a more complete explanation is obtained if the ef-
fect of the mutation on the overall structure of the (AK2^
L38M)2 peptide is included. When L38 is replaced by M38
the intra-monomer side chain packing is enhanced (for both
mutant peptides with and without halothane), which in turn
increases the exposure of C41 to the hydrophobic core, and
hence to the anesthetic. Thus, the enhancement of interactions
Fig. 2. Instantaneous con¢guration of the (a) native (AK2)2 and (b) mutant (AK2^L38M)2 four-K-helix bundles at 1 ns viewed from the side, il-
lustrating the increased exposure of hydrophobic residues in the latter case. The system is colored with respect to the residue hydrophobicity.
Blue corresponds to low and red to high hydrophobicity.
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between halothane and C41 occurs as a result of the e¡ect of
the mutation on the overall structure of the four-K-helix bun-
dle. Furthermore, this large attractive interaction between hal-
othane and C41 can lead to a possible explanation for the
preferred orientation of the anesthetic during the simulation,
if the tri-£uorinated end of halothane is more attracted to the
sulphur atom on C than the end of the molecule with chlorine
and bromine.
The magnitudes of the average interactions between halo-
thane and other residues within the hydrophobic cavity, such
as L27 and F13B, are not signi¢cantly di¡erent compared to
those observed in the native (AK2)2 structure [22]. In partic-
ular, the interactions between halothane and the two W res-
idues are only attractive for one of aromatic side chains. Fur-
thermore, the distances between the center of mass of
halothane and the center of mass of both W side chains ex-
hibit a correlated motion. Both these observations mimic
those found for the native peptide [22]. The angle between
the plane of the indole rings of the two W residues and the
z-direction has smaller £uctuations for the mutant (AK2^
L38M)2 structure than the native, so that in this case the W
residue closest to the halothane does not alter its orientation
signi¢cantly during the simulation. This apparent stability of
the indole ring is probably the result of the preferred orienta-
tion of halothane in the mutant peptide, with the chlorine and
bromine atoms closest to the W ring. This halothane orienta-
tion supports the experimentally observed quenching of the W
£uorescence spectrum by halothane, which is the result of
heavy atom interactions occurring over distances of 3^5
[32,33]. The preferred halothane orientation also decreases
the £uctuations in the motion of the indole ring in the mutant
(AK2^L38M)2 peptide.
4. Conclusions
Several important ¢ndings have emerged from this MD
simulation study. Firstly, a single halothane in the hydropho-
bic cavity of the mutant (AK2^L38M)2 in the anti topology
exhibits a preferred directionality and spatial proximity with
respect to the W residues, in accordance with e⁄cient £uores-
cence quenching observations [15]. Secondly, the mutated res-
idue is not located within the hydrophobic core of this four-K-
helix bundle in the anti topology, and no signi¢cant attractive
interactions exist between halothane and M38. Thus, the e¡ect
of the mutation on the binding a⁄nity of the peptide and
halothane is likely an indirect one. Thirdly, the structural
changes observed in the mutant bundle upon the addition of
halothane are the result of a combination of the improved
packing of side chains between neighboring helices on the
same monomer, which increases the exposure of C41 to the
hydrophobic core, and an increase in the attractive interac-
tions between C41 and the anesthetic. Additionally, the mod-
i¢cation to the K-helicity of the peptide sca¡old due to the
presence of halothane only occurs in a very localized area.
Therefore, it is plausible that a second halothane molecule
can be accommodated in the other, structurally equivalent
hydrophobic cavity in (AK2^L38M)2. The experimental stoi-
chiometry evidence which currently exists cannot quantify the
number of halothane molecules, which are bound to each
peptide bundle at this level of accuracy. However, it is rea-
sonable to assume that each four-K-helix sca¡old can accom-
modate more than one anesthetic molecule, since the existence
of halothane in one cavity does not in£uence the extent of the
other cavity. Further simulations are required before the ef-
fects of the binding of two anesthetic molecules in the two
hydrophobic cavities on the structural features of (AK2^
L38M)2 can be understood. The increased a⁄nity of this mu-
tant structure for halothane observed experimentally [15] may
thus be the result of at least one halothane molecule interact-
ing more strongly with residues such as C41 than in the native
peptide, due to their deeper location in the hydrophobic core
of (AK2^L38M)2.
The cooperative nature of the e¡ects, which the mutation of
a single amino acid residue has on the structural and energetic
features of this synthetic peptide, illustrates the subtle com-
plexity of the interactions involved between anesthetics and
proteins. The ability of computer simulation to pin-point the
variation in the properties of (AK2)2, as a result of a mutation
Fig. 3. Instantaneous con¢guration of the K-helices at 1 ns in the vi-
cinity of the mutation site (viewed from the top) (a) in the absence
and (b) in the presence of halothane. The halogen atoms in halo-
thane are colored as: £uorine in light blue, chlorine in green and
bromine in orange. Only residues associated with the hydrophobic
cavity are shown. Speci¢c residues are colored using the following
code: M38 (orange), C41 (yellow), F12B (pink), L26 (dark blue),
A8B (red), E27 (green), A44 (purple), A55 (pale pink), and A23
(brown). The sulphur atoms in M38 and C41 are black.
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and the addition of halothane, justi¢es the application of this
fundamental theoretical method, and demonstrates the need
to complement experiments with simulations in the study of
anesthetic^protein interactions.
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